Cupid Ltd FY26 Results: Net profit jumps 165% to ₹108 crore
- Net profit grew 165% YoY to ₹108 crore in FY26
- Total income increased 93% YoY to ₹391 crore
- FY27 revenue guidance raised to ₹725-750 crore
- Exports reached ₹208 crore, contributing ~60% of total revenue
- New 170,000 sq. ft. Palava facility commissioned next quarter

*this image is generated using AI for illustrative purposes only.
Cupid Limited reported a 165% increase in profit after tax to ₹108 crore for the year ended March 31, 2026, driven by strong growth in both its global healthcare and domestic consumer businesses. Total income rose 93% to ₹391 crore from ₹203 crore in the previous fiscal year.
The company exceeded its initial FY26 guidance of ₹335 crore revenue and ₹100 crore profit, ending the year with its strongest quarter in history. EBITDA increased 180%, and the net profit margin crossed 30%. Net worth expanded from ₹342 crore to ₹451 crore during the period.
Strategic growth drivers
The performance reflects a transformation driven by new capabilities and wider market reach. The global business, serving national health programmes and multilateral agencies, contributed ₹208 crore in exports, accounting for nearly 60% of revenue across 125+ countries. Cupid remains the first company globally to receive WHO/UNFPA pre-qualification for both male and female condoms.
The consumer business contributed approximately ₹122 crore, including ₹84 crore from recently launched FMCG products. The strategy focuses on scaling from global leadership to consumer scale in Bharat. Key initiatives include:
- Commitment of ₹331.53 crore to Baazar Style Retail, providing access to over 280 stores expected to cross 500 in the next two to three years.
- Development of nitrile capabilities at the new 170,000 sq. ft. Palava facility, scheduled for commissioning next quarter.
- CE certification under European IVDR for HIV, Hepatitis B, Syphilis, and pregnancy test kits.
Post-FY26 developments and guidance
Following the close of FY26, Cupid made an additional USD 5 million follow-on investment in GII Healthcare Investment Limited in July 2026. In August 2026, the Board gave in-principle approval for a proposed manufacturing venture in South Africa, where Cupid is expected to hold up to 49%.
Entering FY27 with momentum, total income grew 142% to ₹157 crore in the June quarter, while profit after tax increased 194% to ₹44 crore. Based on this strength, the company raised its FY27 guidance to:
| Metric | FY27 Guidance |
|---|---|
| Revenue | ₹725-750 crore |
| Net Profit | ₹210-225 crore |
Medium-term targets include FY28 revenue of ₹1,085 crore and FY29 revenue of ₹1,500 crore.
AGM resolutions and board changes
At the 33rd Annual General Meeting held on September 22, 2026, shareholders adopted the audited standalone and consolidated financial statements for FY26. The meeting also approved key board changes through special resolutions:
- Continuation of Thallapaka Venkateswara Rao as Independent Director despite attaining age 75.
- Appointment of Kerala Prasad Yadaw as a new Independent Director.
- Re-appointment of Aditya Kumar Halwasiya as director retiring by rotation.
Remote e-voting facilities were provided from September 18 to September 21, 2026. The AGM concluded at 4:56 pm on September 22, 2026.
What the numbers show
The divergence between the 93% revenue growth and the 165% profit growth indicates significant operating leverage. While revenue nearly doubled, profit more than doubled, suggesting that incremental margins were substantially higher than existing ones. This is further supported by the EBITDA growth of 180%, which outpaced revenue growth, indicating improved cost efficiency or a favorable product mix shift towards higher-margin segments like the newly launched FMCG products which contributed ₹84 crore.
Historical Stock Returns for Cupid
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.39% | -3.28% | -5.73% | +235.20% | +508.25% | +11,742.11% |
How will the commissioning of the Palava facility's nitrile capabilities specifically impact Cupid's gross margin trajectory in FY27?
What are the projected revenue contributions from the Baazar Style Retail partnership as the store count scales toward 500 locations?
How might the proposed South Africa manufacturing venture influence Cupid's export logistics and regulatory compliance costs in African markets?

































